RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 8.361
EU - Europa 7.356
AS - Asia 4.830
SA - Sud America 614
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 6
Totale 21.247
Nazione #
US - Stati Uniti d'America 8.244
CN - Cina 1.833
IE - Irlanda 1.649
SG - Singapore 1.586
UA - Ucraina 1.099
IT - Italia 972
RU - Federazione Russa 913
SE - Svezia 857
DE - Germania 611
BR - Brasile 505
FR - Francia 472
HK - Hong Kong 407
FI - Finlandia 375
IN - India 295
TR - Turchia 251
VN - Vietnam 207
GB - Regno Unito 150
CZ - Repubblica Ceca 60
CA - Canada 58
BD - Bangladesh 54
NL - Olanda 54
MX - Messico 35
AR - Argentina 34
BE - Belgio 34
JP - Giappone 30
AT - Austria 28
IQ - Iraq 26
ES - Italia 25
PL - Polonia 24
ZA - Sudafrica 22
PK - Pakistan 19
EC - Ecuador 18
CL - Cile 14
PH - Filippine 13
VE - Venezuela 13
PY - Paraguay 12
AZ - Azerbaigian 11
ID - Indonesia 11
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
UZ - Uzbekistan 11
SA - Arabia Saudita 10
EU - Europa 9
KE - Kenya 8
MY - Malesia 8
CO - Colombia 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
ET - Etiopia 5
IL - Israele 5
JM - Giamaica 5
RO - Romania 5
UY - Uruguay 5
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
LB - Libano 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CM - Camerun 2
DZ - Algeria 2
KW - Kuwait 2
NG - Nigeria 2
PT - Portogallo 2
QA - Qatar 2
SR - Suriname 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
Totale 21.236
Città #
Dublin 1.649
San Jose 1.351
Chandler 999
Singapore 792
Jacksonville 773
Ashburn 564
Nyköping 548
Dearborn 541
Munich 412
Hong Kong 402
Nanjing 380
Beijing 334
Dallas 246
New York 240
Wilmington 239
Santa Clara 221
Helsinki 206
Princeton 179
Lauterbourg 169
San Mateo 157
Nanchang 145
Ann Arbor 122
Boardman 119
Moscow 117
Foggia 98
Shenyang 85
Woodbridge 83
The Dalles 80
Bari 79
Los Angeles 76
Des Moines 73
Ho Chi Minh City 72
Tianjin 69
Hebei 68
Milan 66
Rome 58
Brno 53
Seattle 53
Kunming 51
Hanoi 47
Jiaxing 45
Changsha 44
São Paulo 38
Pune 37
Hangzhou 34
Jinan 30
Brussels 29
Falls Church 29
Shanghai 29
Guangzhou 28
Tokyo 27
Toronto 26
Brooklyn 25
Hilden 25
Zhengzhou 25
Ningbo 23
San Francisco 22
Augusta 20
Frankfurt am Main 20
Warsaw 20
London 19
Naples 19
Rio de Janeiro 19
Houston 18
Noci 17
Norwalk 17
Taizhou 17
Changchun 16
Lanzhou 16
Fuzhou 15
Stevenage 15
Belo Horizonte 14
Chicago 14
Florence 14
Orem 14
Atlanta 13
Auburn Hills 13
Hillsboro 12
Manchester 12
Nuremberg 12
Chennai 11
Mexico City 11
Paris 11
Phoenix 11
Turku 11
Vienna 11
Catania 10
Manfredonia 10
Saint Petersburg 10
Stockholm 10
Amman 9
Baghdad 9
Baku 9
Bologna 9
Boston 9
Council Bluffs 9
Falkenstein 9
Haiphong 9
Johannesburg 9
Jyväskylä 9
Totale 13.094
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 498
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 282
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 274
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 265
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 255
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 184
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 174
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 167
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 165
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 164
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 164
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 162
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 161
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 161
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 160
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 159
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 158
cell carcinoma cell line and use thereof. 155
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 152
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 151
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 149
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 147
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 147
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 146
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 144
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 140
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 139
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 139
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 138
IgA nephropathy: pros and cons for a familial disease. 137
Renal cortical complement C3 gene expression in IgA nephropathy 137
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 137
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 135
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 134
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 133
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 133
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 132
Renal and upper urinary tract tumors: what the nephrologist should know 131
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 131
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 131
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 131
Renal Carcinoma Cell Line and Use Thereof 130
Linea cellulare di carcinoma renale e suo uso 130
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 129
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 129
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 128
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 127
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 127
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 126
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 125
Biosimilar: can we manage biopharmaceutical heterogeneity? 123
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 123
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 123
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 122
Salivary proteomic signatures of oral squamous cell carcinoma. 122
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 121
Diagnostic and prognostic markers of renal cell carcinoma 121
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 121
Reclassification of glomerulopathies: which role for the podocyte? 120
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 120
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 119
CD40 cross-linking induces migration of renal tumor cell through nuclear factor of activated T cells (NFAT) activation 119
Urinary epidermal growth factor concentration in patients affected by ADPKD. 118
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 118
Altered expression of the clock gene machinery in kidney cancer patients 118
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 118
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 118
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 117
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 117
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 116
Is Berger's disease a hereditary nephritis? 116
Immunologic Response to RCC. 116
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 116
Growth factors and their receptors in the progression of renal damage. 116
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 116
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 115
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 114
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 113
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 113
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 112
Monitoring biological action of rapamycin in renal transplantation. 112
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 112
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review 111
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 110
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 109
TLR7 and TLR8 as targets for tumor immunotherapy 109
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 108
Platelet-derived growth factor and proliferative glomerulonephritis. 107
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 107
Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy 106
LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis 106
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 105
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 105
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 105
VHL gene alterations in Italian patients with isolated renal cell carcinomas. 105
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 105
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 104
Cytotoxic T-Cells Methods and Protocols Preface 104
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 103
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. 103
Totale 13.730
Categoria #
all - tutte 112.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/20221.139 157 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20253.410 196 47 113 103 125 454 481 268 815 175 334 299
2025/20265.685 322 509 556 690 277 214 1.317 590 432 407 155 216
Totale 21.777